(Q36257253)

13 August 2017

title

Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure (English)

1 reference

13 August 2017

0 references

1 reference

4

Seng-Gee Lim

1 reference

13 August 2017

3

Dede Selamat Sutedja

1 reference

13 August 2017

Kang-Hoe Lee

1

1 reference

13 August 2017

Margaret Kwee-Hiang Lee

series ordinal

2

1 reference

13 August 2017

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

25

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

973-977

1 reference

Early indicators of prognosis in fulminant hepatic failure

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Etiology and outcome for 295 patients with acute liver failure in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Liver support by extracorporeal blood purification: a clinical observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Use of MARS in the treatment of acute liver failure: preliminar monocentric experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Experience with albumin dialysis in five patients with severe overdoses of paracetamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Effect of an experimental stenosis in the porcine descending thoracic aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

21 January 2018

Herbal hepatotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01091.X

10.1111/J.1478-3231.2005.01091.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference